Patents by Inventor Peter Scammells

Peter Scammells has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MAPK inhibitors
    Patent number: 11273153
    Abstract: The present invention relates to certain novel substituted thiophene compounds and the finding that they display useful efficacy in the inhibition of the p38? MAPK enzyme. This provides for use of the compounds in various treatment methodologies related to MAPK inhibition, including the treatment of inflammation.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: March 15, 2022
    Assignee: EverBrilliant Pharma Pty Ltd
    Inventors: Henry Krum, Peter Scammells, Bing Wang, Natalie Vinh, Jamie Simpson, David Chalmers
  • MAPK INHIBITORS
    Publication number: 20180289684
    Abstract: The present invention relates to certain novel substituted thiophene compounds and the finding that they display useful efficacy in the inhibition of the p38? MAPK enzyme. This provides for use of the compounds in various treatment methodologies related to MAPK inhibition, including the treatment of inflammation.
    Type: Application
    Filed: June 12, 2018
    Publication date: October 11, 2018
    Inventors: Henry Krum, Peter Scammells, Bing Wang, Natalie Vinh, Jamie Simpson, David Chalmers
  • COMPOSITIONS AND PREPARATION METHODS OF LOW MELTING IONIC SALTS OF POORLY-WATER SOLUBLE DRUGS
    Publication number: 20160151503
    Abstract: The disclosure relates generally to ionic salts, particularly low-melting ionic salts such as ionic liquids, of poorly-water soluble drugs. The disclosure further relates to methods of preparing the ionic salts of poorly-water soluble drugs, lipid formulations comprising them and their use in drug delivery.
    Type: Application
    Filed: August 1, 2014
    Publication date: June 2, 2016
    Applicant: MW ENCAP LIMITED
    Inventors: Chris Porter, Peter Scammells, Hywel Williams, Yasemin Sahbaz
  • Chemical methods
    Patent number: 7405301
    Abstract: This invention relates to a method for N-demethylating an N-methyl morphinane comprising the steps of: (i) treating said N-methyl morphinane with an oxidizing agent to form the N-oxide morphinane; and (ii) treating said N-oxide morphinane with a reducing agent. This invention also relates to a method for oxidizing a ?7-morphinane compound to a ?6, ?8-morphinane compound, comprising the steps of treating said ?7-morphinane with ?-MnO2 for a time and under conditions sufficient to oxidize said ?7-morphinane, and treating the ?-MnO2 with glycol or a derivative thereof, and/or an inorganic salt.
    Type: Grant
    Filed: August 24, 2001
    Date of Patent: July 29, 2008
    Assignee: GlaxoWellcome Australia Ltd.
    Inventors: Peter Scammells, Nicholas Gathergood, Justin Ripper
  • Chemical methods
    Publication number: 20040077863
    Abstract: This invention relates to a method for N-demethylating an N-methyl morphinane comprising the steps of: (i) treating said N-methyl morphinane with an oxidizing agent to form the N-oxide morphinane; and (ii) treating said N-oxide morphinane with a reducing agent. This invention also relates to a method for oxidizing a &Dgr;7-morphinane compound to a &Dgr;6, &Dgr;8-morphinane compound, comprising the steps of treating said &Dgr;7-morphinane with &ggr;-MnO2 for a time and under conditions sufficient to oxidize said &Dgr;7morphinane, and treating the &ggr;-MnO2 with glycol or a derivative thereof, and/or an inorganic salt.
    Type: Application
    Filed: December 2, 2003
    Publication date: April 22, 2004
    Inventors: Peter Scammells, Nicholas Gathergood, Justin Ripper